Cabergoline 0.5mg Tablets
Cabergoline is a long-acting dopamine receptor agonist used to treat conditions associated with elevated prolactin hormone levels. Excess prolactin can lead to symptoms such as menstrual irregularities, infertility, reduced libido, and other hormone-related concerns.
Cabergoline works by stimulating dopamine receptors in the pituitary gland, helping to suppress excess prolactin production and support hormonal balance. Due to its long duration of action, Cabergoline is often prescribed with infrequent dosing schedules as determined by a healthcare professional.
Key Benefits
✅ Supports management of elevated prolactin levels under medical supervision
✅ Long-acting formula with convenient dosing schedule
✅ Popular among fitness enthusiasts who monitor hormone-related biomarkers
✅ May help support overall hormonal balance when prolactin levels are elevated
✅ Widely recognized pharmaceutical-grade Cabergoline formulation
✅ Trusted medication prescribed for prolactin-related conditions
How to Use
- Take Caberlog exactly as prescribed by your healthcare provider.
- Swallow the tablet with water.
- May be taken with food to improve tolerability.
- Follow your prescribed dosing schedule and do not exceed the recommended dose.
Specifications
| Attribute | Details |
|---|---|
| Brand | Caberlog |
| Active Ingredient | Cabergoline |
| Strength | 0.5mg |
| Form | Oral Tablet |
| Pack Size | 8 Tablets |
| Drug Class | Dopamine Agonist |
| Intended Use | Management of Hyperprolactinemia |
| Administration | Oral |
| Prescription Status | Follow local regulations |
Storage
Store at room temperature in a dry place away from heat, moisture, and direct sunlight. Keep out of reach of children.
Safety Information
- Use only under the supervision of a qualified healthcare professional.
- Inform your healthcare provider about any heart, liver, or blood pressure conditions before use.
- May cause dizziness, drowsiness, nausea, or headaches in some individuals.
- Avoid driving or operating machinery if dizziness or drowsiness occurs.
- Regular medical monitoring may be recommended during treatment.




